| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/20/2011 | US20110014642 Method of screening for compounds that can be used for the treatment of respiratory conditions |
| 01/20/2011 | US20110014641 Method for measuring aromatase activity |
| 01/20/2011 | US20110014640 Blood coagulation analyzer, blood coagulation analysis method, and computer program product |
| 01/20/2011 | US20110014636 Method of detecting leukemic cell |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/20/2011 | US20110014625 System and Method for Determining the Health of a Subject Using Polymorphic Risk Markers |
| 01/20/2011 | US20110014624 Methods For Identifying Cells Suitable For Large-Scale Production of Recombinant Proteins |
| 01/20/2011 | US20110014623 Tagged oligonucleotides and their use in nucleic acid amplification methods |
| 01/20/2011 | US20110014622 Genetic reference materials |
| 01/20/2011 | US20110014621 Detecting multinucleotide repeats |
| 01/20/2011 | US20110014620 Methods for identification of bone anabolic agents |
| 01/20/2011 | US20110014619 Reaction treatment apparatus and reaction treatment method |
| 01/20/2011 | US20110014618 Detection of nucleic acids and proteins |
| 01/20/2011 | US20110014617 Methods and Systems for Detecting Nucleic Acids |
| 01/20/2011 | US20110014616 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
| 01/20/2011 | US20110014615 METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8 |
| 01/20/2011 | US20110014614 Method of profiling gene expression in a subject having an infectious disease |
| 01/20/2011 | US20110014613 Genotyping for Risk of Atherosclerosis |
| 01/20/2011 | US20110014612 Polymerase compositions & methods |
| 01/20/2011 | US20110014611 Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
| 01/20/2011 | US20110014610 Compositions and methods for diagnosing and treating neuropsychiatric disorders |
| 01/20/2011 | US20110014609 Nucleic acid signal enhancement using nanoparticle-based hybridization |
| 01/20/2011 | US20110014608 SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES |
| 01/20/2011 | US20110014607 Imprinted genes and disease |
| 01/20/2011 | US20110014606 Assays |
| 01/20/2011 | US20110014605 Methods and systems for dna isolation on a microfluidic device |
| 01/20/2011 | US20110014604 Methods for sequence determination |
| 01/20/2011 | US20110014603 Targets for use in diagnosis, prognosis and therapy of cancer |
| 01/20/2011 | US20110014602 Diagnostic composition for hepatocellular carcinoma, a diagnostic kit comprising it and diagnostic methods of hepatocellular carcinoma |
| 01/20/2011 | US20110014601 Targeted Chromosomal Mutagenesis Using Zinc Finger Nucleases |
| 01/20/2011 | US20110014600 Microfluidic Magnetophoretic Device and Methods for Using the Same |
| 01/20/2011 | US20110014599 Novel Fluorescent Dyes and Uses Thereof |
| 01/20/2011 | US20110014598 Optimized probes and primers and method of using same for the detection of herpes simplex virus |
| 01/20/2011 | US20110014597 Perfusable Bioreactor for the Production and/or Cultivation of a Human or Animal Blood Vessel and/or a Human or Animal Tissue |
| 01/20/2011 | US20110014231 Anti-measles cancer immunotherapy |
| 01/20/2011 | US20110014229 Chimeric flavivirus vectors |
| 01/20/2011 | US20110014214 Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014206 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 01/20/2011 | US20110014204 Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2 |
| 01/20/2011 | US20110014202 Methods for Diagnosing and Treating Neuroendocrine Cancer |
| 01/20/2011 | US20110014197 Methods of treating pre-eclampsia or eclampsia |
| 01/20/2011 | US20110014191 Breast cancer expression profiling |
| 01/20/2011 | US20110014185 Methods involving graf polypeptides |
| 01/20/2011 | US20110014184 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 01/20/2011 | US20110014183 Mcam modulation and uses thereof |
| 01/20/2011 | US20110014175 Stimulation of the synthesis of the activity of an isoform of lysl oxidase-like loxl for stimulating the formation of elastic fibres |
| 01/20/2011 | US20110014126 Use of vitamin d receptor agonists and precursors to treat fibrosis |
| 01/20/2011 | US20110014125 Protease assay |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | DE102009032502A1 Detektion von Antigenen Detection of antigens |
| 01/20/2011 | DE102006059294B4 Methylierungsinhibitor für eine eukaryontische Nukleinsäure-Methylierungsreaktion, dessen Verwendung, Inhibierungsverfahren und Bestimmungsverfahren der Inhibierungswirkung Methylation inhibitor of a eukaryotic nucleic acid methylation reaction, its use, inhibition process and methods of determination of the inhibitory |
| 01/20/2011 | CA2768478A1 Detection of short rna sequences |
| 01/20/2011 | CA2768475A1 Methods and kits used in assessing cancer risk |
| 01/20/2011 | CA2768352A1 Novel fluorescent dyes and uses thereof |
| 01/20/2011 | CA2768241A1 A mechanism and method for regulating glycogen synthase kinase 3 (gsk3)-related kinases |
| 01/20/2011 | CA2767955A1 Method for determining the sensitivity or resistance of retrovirus isolates to molecules, therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits |
| 01/20/2011 | CA2767570A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | CA2767128A1 Biomarker er2 for gynaecological cancer |
| 01/20/2011 | CA2767122A1 Biomarker |
| 01/20/2011 | CA2766403A1 Diagnostic methods and compositions for treatment of cancer |
| 01/20/2011 | CA2766351A1 Chimeric primers with hairpin conformations and methods of using same |
| 01/20/2011 | CA2763420A1 Mass spectrometric diagnosis of septicemia |
| 01/20/2011 | CA2759493A1 Method for screening for diet providing production of milk having immunoregulatory action |
| 01/19/2011 | EP2275817A1 Proteolytic enzymes in diagnosis of kidney disorders |
| 01/19/2011 | EP2275816A2 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases |
| 01/19/2011 | EP2275807A1 Biosensor for quantifying a substrate |
| 01/19/2011 | EP2275579A2 Primer pair for the detection of a gene (VIP3A) encoding an insecticide |
| 01/19/2011 | EP2275578A2 Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma |
| 01/19/2011 | EP2275577A1 Nucleic acid compaction method |
| 01/19/2011 | EP2275576A1 High throughput physical mapping using AFLP |
| 01/19/2011 | EP2275575A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275574A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275573A1 Antibodies for treating and diagnosing gastric adenocarcinoma |
| 01/19/2011 | EP2275572A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275571A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275570A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275569A1 ZNF217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in cancer |
| 01/19/2011 | EP2275568A1 Marker sequences for obesity and use of same |
| 01/19/2011 | EP2275567A1 Nucleic acid expression construct and its use as a cell proliferation marker |
| 01/19/2011 | EP2275561A1 Soybean Event MON89788 and methods for detection thereof |
| 01/19/2011 | EP2275558A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/19/2011 | EP2275556A1 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 01/19/2011 | EP2275555A2 Genetic sequence coding for creatinine deiminase, and its use |
| 01/19/2011 | EP2275549A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/19/2011 | EP2275547A2 Polynucleotides and polypeptide sequences involved in the process of bonne remodeling |
| 01/19/2011 | EP2275546A2 Enzymatic DNA molecules |
| 01/19/2011 | EP2275544A2 Genes and polypeptides relating to human colon cancers |
| 01/19/2011 | EP2275542A2 Method for identifying useful proteins of brewery yeast |
| 01/19/2011 | EP2275539A2 A kit for judging risk for onset of drug-induced granulocytopenia |
| 01/19/2011 | EP2275538A1 Novel dna capable of being amplified by pcr with high selectivity and high efficiency |
| 01/19/2011 | EP2275536A1 AP1 amine oxidase variants |
| 01/19/2011 | EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof |
| 01/19/2011 | EP2275463A1 Support for electrophoresis containing a composition and method |
| 01/19/2011 | EP2275448A2 Monovalent antibody fragments useful as therapeutics |
| 01/19/2011 | EP2275447A1 Methods of inhibiting metastasis |
| 01/19/2011 | EP2275435A2 Streptococcus agalactiae antigens I + II |
| 01/19/2011 | EP2275118A2 Pancreas-specific proteins |
| 01/19/2011 | EP2274974A1 Closterovirus-resistant melon plants |
| 01/19/2011 | EP2274617A2 Methods for identification and use of agents targeting cancer stem cells |